Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,143 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $398.74 | 28 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $246.15 | 12 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $124.57 | 6 | $0 (2021) |
| Alkermes, Inc. | $108.91 | 5 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $98.73 | 6 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $51.69 | 3 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $45.72 | 4 | $0 (2018) |
| Lundbeck LLC | $32.17 | 2 | $0 (2019) |
| ABBVIE INC. | $24.01 | 1 | $0 (2022) |
| Allergan Inc. | $12.67 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $34.62 | 2 | Otsuka America Pharmaceutical, Inc. ($34.62) |
| 2022 | $72.82 | 3 | Teva Pharmaceuticals USA, Inc. ($25.87) |
| 2021 | $70.91 | 3 | Alkermes, Inc. ($26.41) |
| 2020 | $54.24 | 3 | Sunovion Pharmaceuticals Inc. ($19.44) |
| 2019 | $371.46 | 22 | Sunovion Pharmaceuticals Inc. ($180.26) |
| 2018 | $271.84 | 20 | Sunovion Pharmaceuticals Inc. ($101.30) |
| 2017 | $267.47 | 15 | Janssen Pharmaceuticals, Inc ($125.79) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Central Nervous System | ||||||
| 08/04/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CNS | ||||||
| 07/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Neuroscience | ||||||
| 04/22/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: CNS | ||||||
| 03/03/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/20/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CNS | ||||||
| 02/06/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Central Nervous System | ||||||
| 12/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CNS | ||||||
| 12/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: CNS | ||||||
| 11/21/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: CNS | ||||||
| 11/14/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Neuroscience | ||||||
| 11/07/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Central Nervous System | ||||||
| 11/06/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: CNS | ||||||
| 10/24/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Central Nervous System | ||||||
| 09/05/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: CNS | ||||||
| 08/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CNS | ||||||
| 08/29/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Central Nervous System | ||||||
| 08/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CNS | ||||||
| 07/11/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: CNS | ||||||
| 06/06/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,433 | 1,929 | $271,900 | $167,750 |
| 2022 | 14 | 1,542 | 2,095 | $317,204 | $180,778 |
| 2021 | 12 | 989 | 1,671 | $235,600 | $148,045 |
| 2020 | 14 | 2,072 | 3,092 | $430,711 | $248,409 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 436 | 543 | $81,500 | $47,457 | 58.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 458 | $57,250 | $44,834 | 78.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 454 | 468 | $46,800 | $29,573 | 63.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 126 | 126 | $31,500 | $16,761 | 53.2% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 95 | 96 | $18,550 | $9,468 | 51.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 33 | $8,250 | $4,922 | 59.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 43 | $6,450 | $4,317 | 66.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 71 | 73 | $7,300 | $3,847 | 52.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 55 | 59 | $8,250 | $3,571 | 43.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 30 | 30 | $6,050 | $2,999 | 49.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 90 | 523 | $66,050 | $47,192 | 71.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 241 | 242 | $60,500 | $30,750 | 50.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 299 | 354 | $53,900 | $26,625 | 49.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 393 | 448 | $45,150 | $24,554 | 54.4% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 153 | 153 | $30,600 | $16,210 | 53.0% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 127 | 130 | $19,850 | $9,794 | 49.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $9,100 | $6,246 | 68.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 56 | 59 | $8,850 | $5,514 | 62.3% |
| 99327 | New patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 23 | 23 | $5,200 | $3,409 | 65.6% |
| 99328 | New patient custodial care facility, group care, or assisted living visit, typically 75 minutes | Office | 2022 | 14 | 14 | $3,500 | $2,617 | 74.8% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 23 | 23 | $4,200 | $2,530 | 60.2% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 38 | 38 | $3,800 | $1,830 | 48.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,000 | $1,592 | 53.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 19 | 20 | $1,804 | $1,017 | 56.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 16 | 17 | $1,700 | $898.16 | 52.8% |
About Dr. Umar Rahman, MD
Dr. Umar Rahman, MD is a Psychiatry healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376633321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Umar Rahman, MD has received a total of $1,143 in payments from pharmaceutical and medical device companies, with $34.62 received in 2023. These payments were reported across 68 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,143).
As a Medicare-enrolled provider, Rahman has provided services to 6,036 Medicare beneficiaries, totaling 8,787 services with total Medicare billing of $744,982. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Silver Spring, MD
- Active Since 10/13/2006
- Last Updated 06/19/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1376633321
Products in Payments
- LATUDA (Drug) $398.74
- INVEGA SUSTENNA (Drug) $227.19
- NUPLAZID (Drug) $124.57
- AUSTEDO (Drug) $98.73
- ARISTADA (Drug) $88.88
- ABILIFY MAINTENA (Drug) $49.24
- VRAYLAR (Drug) $36.68
- REXULTI (Drug) $34.62
- Fanapt (Drug) $33.73
- Aristada 441 mg (Drug) $20.03
- INVEGA TRINZA (Drug) $18.96
- Hetlioz (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Silver Spring
Dr. Ghislaine Fougy, Md, MD
Psychiatry — Payments: $3,016
Dr. Christopher Nelson, M.d, M.D
Psychiatry — Payments: $791.46
Naveen Maddineni, M.d, M.D
Psychiatry — Payments: $499.52
Joseph Hibbeln, Md, MD
Psychiatry — Payments: $338.78
Dr. Shira Rubinstein, M.d, M.D
Psychiatry — Payments: $134.72
Teodor Postolache, M.d, M.D
Psychiatry — Payments: $123.35